首页> 外文期刊>Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts >Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016)

【24h】

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016)

机译：在骨髓瘤中使用新型CD38单克隆抗体Daratumumab的实践考虑（vol 76，pg 853，2016）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts》 |2016年第9期|共2页
作者
Moreau Philippe; van de Donk Niels W. C. J.; San Miguel Jesus; Lokhorst Henk; Nahi Hareth; Ben-Yehuda Dina; Cavo Michele; Cook Gordon; Delforge Michel; Einsele Hermann; Zweegman Sonja; Ludwig Heinz; Driessen Christoph; Palumbo Antonio; Facon Thierry; Plesner Torben; Dimopoulos Meletios; Sondergeld Pia; Sonneveld Pieter; Mateos Maria-Victoria;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016) [J] . Moreau Philippe, van de Donk Niels W. C. J., San Miguel Jesus, Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2016,第9期

机译：在骨髓瘤中使用新型CD38单克隆抗体Daratumumab的实践考虑（vol 76，pg 853，2016）
2. Considerations for pre‐transfusion immunohaematology testing in patients receiving the anti‐CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma [J] . Quach Hang, Benson Simon, Haysom Helen, Internal medicine journal . 2018,第2期

机译：用于接受抗CD38单克隆抗体达拉汀治疗多发性骨髓瘤的患者患者预输血免疫中心病学检测的考虑
3. Considerations for pre‐transfusion immunohaematology testing in patients receiving the anti‐CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma [J] . Quach Hang, Benson Simon, Haysom Helen, Internal medicine journal . 2018,第Suppla2期

机译：用于接受抗CD38单克隆抗体达拉汀治疗多发性骨髓瘤的患者患者预输血免疫中心病学检测的考虑
4. Comparative Proteomic Study of Mechanisms Involved in the Expression of Recombinant Monoclonal Antibody in Non Amplified NSO Myeloma Cell Line [C] . Luis E. Rojas, Kathya R. de la Luz Hernandez, Svieta Victores, General Meeting of European Society of Animal Cell Technology . 2007

机译：对非扩增NSO骨髓瘤细胞系重组单克隆抗体表达的机制的比较蛋白质组学研究
5. Affinity Precipitation of Monoclonal Antibodies Using Stimuli Responsive Smart Biopolymers: Methods Development and Process Considerations. [D] . Sheth, Rahul Dinesh. 2014

机译：使用刺激性反应灵敏的生物聚合物对单克隆抗体进行亲和沉淀：方法开发和工艺考虑。
6. Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab [O] . Michael. S. van der Veer, Michel de Weers, Berris van Kessel, 2011

机译：迈向有效的骨髓瘤免疫治疗：通过来那度胺与人CD38单克隆抗体daratumumab的组合增强对骨髓瘤细胞的清除
7. Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab [O] . van der Veer, Michael. S., de Weers, Michel, van Kessel, Berris, 2010

机译：迈向有效的骨髓瘤免疫治疗：通过来那度胺与人CD38单克隆抗体daratumumab的组合，增强对骨髓瘤细胞的清除

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号